Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

July 24, 2020July 24, 2020

Inhaled Antibiotics Lower Flare Risk in Non-CF Bronchiectasis, But Have Limits

News

Inhaled antibiotics can effectively kill bacteria and lessen exacerbations in people with stable non-cystic fibrosis bronchiectasis (NCFB), but they do not improve lung function or life quality, a review study ... Read more

June 26, 2020June 26, 2020

Flare Risk Drops if Brensocatib Clears Key Protein from NCFBE Patient Sputum, Trial Finds

News

Adults with non-cystic fibrosis bronchiectasis (NCFBE) who were given brensocatib in a Phase 2 trial were 72% less likely to be at risk of an exacerbation if neutrophil elastase in their sputum fell to undetectable ... Read more

June 8, 2020June 8, 2020

Cardiovascular Disease Raises Risk of Bronchiectasis Exacerbations, Study Reports

News

Cardiovascular disease (CVD) raises the risk of exacerbations in people with bronchiectasis, a new study reports. The study, “Clinical impact of cardiovascular disease on patients with bronchiectasis,” was published in ... Read more

June 5, 2020June 5, 2020

UK Survey: Reduced Pollution Due to COVID-19 Benefits People with Lung Conditions

News

The decrease in air pollution associated with the COVID-19 pandemic has eased symptoms in many people with lung conditions, including bronchiectasis, a new survey from the British Lung Foundation (BLF) ... Read more

April 27, 2020April 27, 2020

Brensocatib, Potential Bronchiectasis Therapy, to Enter COVID-19 Trial

News

Brensocatib, an oral investigational therapy being developed to treat bronchiectasis, will be tested in people with a severe COVID-19 infection in an upcoming clinical trial, Insmed, its developer, announced. The trial, ... Read more

March 9, 2020March 9, 2020

Air Pollution Raises Risk of Bronchiectasis-related Hospitalizations in Iran, Study Finds

News

Higher levels of air pollutants increase the risk of hospitalizations for lung-associated conditions, including bronchiectasis, asthma, and chronic obstructive pulmonary disease (COPD), an Iranian study has found. The study, “Acute ... Read more

December 19, 2019December 19, 2019

Care of Children with Bronchiectasis Lags Those with Cystic Fibrosis, Australian Study Finds

News

Children with bronchiectasis have poorer lung function than those with cystic fibrosis (CF), likely because of the differing levels of care given to children with these conditions, an Australian study suggests. ... Read more

September 26, 2019September 26, 2019

Study Examines Risk Factors for Bacterial Colonization in Bronchiectasis

News

Among people with bronchiectasis, those more than 55 years old or who have bronchiectasis as a result of infection, are at an increased risk of being colonized with the bacteria Pseudomonas ... Read more

August 29, 2019August 29, 2019

New Distribution Partnerships for SmartVest System Announced

News

Electromed has entered into new agreements with two home medical equipment distributors to enhance the distribution of and facilitate access to its SmartVest Airway Clearance System for people with respiratory ... Read more

August 15, 2019

More Studies Needed on Antibiotic Use in Children With Bronchiectasis, Review Finds

News

A lack of data on the use of different antibiotics to treat and/or prevent acute exacerbations in children with bronchiectasis highlights the need for more research in this area, a ... Read more